Conclusion
As summarized above, cumulative epidemiologic data consistently demonstrate that the incidence of gastric cancer in the U.S. varies according to ethnicity, immigrant status, and country of origin. New gastroenterologists will need to recognize individual risk profiles and identify people at higher risk for gastric cancer. Risk stratification before performing endoscopic evaluation will improve early gastric cancer detection and make noninvasive, effective therapies an option.
References
1. Surveillance, Epidemiology, and End Results Program cancer statistics. https://seer.cancer.gov/statfacts/html/stomach.html.
2. Bray F et al. Ca Cancer J Clin. 2018;68:394-424.
3. Ferro A et al. Eur J Cancer. 2014;50:1330-44.
4. Luo G et al. Int J Cancer. 2017;141:1333-44.
5. Arnold M et al. Eur J Cancer. 2015;51:1164-87.
6. Thrift AP, El-Serag HB. Clin Gastroenterol Hepatol. 2020;18:534-42.
7. Kim Y et al. Epidemiol Health. 2015;37:e2015066.
8. Kamineni A et al. Cancer Causes Control. 1999;10:77-83.
9. Pabla BS et al. Clin Gastroenterol Hepatol. 2020;18:347-59.
10. Shah SC et al. Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk. Gut Liver. 2018 Jan 15;12(1):38-45.
11. International Agency for Research on Cancer. Monographs on the Identification of Carcinogenic Hazards to Humans. IARC. July 7, 2019. 12. Uemura N et al. N Engl J Med. 2001;345:784-9.
13. Lee YC et al. Gastroenterology. 2016;150:1113-24.
14. Ford AC et al. BMJ. 2014;348:g3174.
15. Chey W et al. Am J Gastroenterol. 2017;112:212-39.
16. Kumar S et al. Gastroenterology. 2020;158:527-36.
17. Kumar S et al. Clin Gastroenterol Hepatol. 2020 Apr 6;S1542-3565(20)30436-5.
18. González CA et al. Int J Cancer. 2003;107:629-34.
19. Ladeiras-Lopes R et al. Cancer Causes Control. 2008;19:689-701.
20. Cavaleiro-Pinto M et al. Cancer Causes Control. 2011;22:375-87.
21. Lauby-Secretan B et al. N Engl J Med. 2016;375:794-8.
22. Choi IJ et al. N Engl J Med. 2020;382:427-36.
23. Kim BJ et al. World J Gastroenterol. 2013;19:736-41.
24. Hamashima C. Jpn J Clin Oncol. 2018;48:278–86.
25. Saumoy M et al. Gastroenterology. 2018;155:648-60.
26. Shah SC et al. Clin Gastroenterol Hepatol. 2020 Jul 21:S1542-3565(20)30993-9. doi: 10.1016/j.cgh.2020.07.031.
27. Brinton LA et al. Br J Cancer. 1989;59:810-3.
28. Hsing AW et al. Cancer. 1993;71:745-50.
29. Schafer LW et al. Mayo Clin Proc. 1985;60:444-8.
30. American Society for Gastrointestinal Endoscopy Standards of Practice Committee. Gastrointest Endosc. 2015;82:1-8.
31. Chiu PWY et al. Gut. 2019;68:186-97.
32. Pimentel-Nunes P et al. Endoscopy. 2012;44:236-46.
33. Pimentel-Nunes P et al. Endoscopy. 2016;48:723-30.
34. Participants in the Paris Workshop. Gastrointest Endosc. 2003;58:S3-43.
35. Draganov PV et al. Clin Gastroenterol Hepatol. 2019;17:16-25.
36. Ngamruengphong S et al. Clin Gastroenterol Hepatol. 2020 Jun 18;S1542-3565(20)30834-X. Online ahead of print.
37. Choi IJ et al. N Engl J Med. 2018;378:1085-95.
Dr. Tomizawa is a clinical assistant professor of medicine in the division of gastroenterology, University of Washington, Seattle.
